Moleculin Biotech MBRX
NASDAQ MBRX
$0.51 -0.02 (-3.15%)
As of: Sep 30, 2026 · 1:58 PM EDT

Moleculin Biotech, Inc. (MBRX) Total Non-Current Liabilities (2015 - 2026)

Updated

Moleculin Biotech's Total Non-Current Liabilities was $9.46 million in Q2 2026, up 104.6% from $4.62 million a year earlier.

Analysis

Moleculin Biotech, Inc. (MBRX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Moleculin Biotech came in at $7.08 million, up 23.8% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of 18.1% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $5.72 million in FY2024 (+134.9%), $2.43 million in FY2023 (-52.8%), $5.15 million in FY2022 (+39.9%) and $3.69 million in FY2021 (+19.7%).
  • The Q2 2026 figure marks the highest quarterly Total Non-Current Liabilities since Q3 2019.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q1 2025 (growth of 193.8%); the worst was Q1 2024 (a decline of 54.0%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.46 Mn
Dec 31, 2025 7.08 Mn
Sep 30, 2025 5.94 Mn
Jun 30, 2025 4.62 Mn
Mar 31, 2025 7.22 Mn
Dec 31, 2024 5.72 Mn
Sep 30, 2024 -3.95 Mn
Jun 30, 2024 4.46 Mn
Mar 31, 2024 2.46 Mn
Dec 31, 2023 2.43 Mn
Sep 30, 2023 4.38 Mn
Jun 30, 2023 6.85 Mn
Mar 31, 2023 5.34 Mn
Dec 31, 2022 5.15 Mn
Sep 30, 2022 6.73 Mn
Jun 30, 2022 6.25 Mn
Mar 31, 2022 4.88 Mn
Dec 31, 2021 3.69 Mn
Sep 30, 2021 3.73 Mn
Jun 30, 2021 3.44 Mn
API Access

Moleculin Biotech, Inc. Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MBRX&period=max&api_key=YOUR_API_KEY